금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
CPI Inflation Overshoots, Putting Fed Hike In Play; S&P 500 Futures Fall, Yields Jump (Live Coverage)
September core CPI inflation rose more than expected, keeping an October Fed rate hike in play. Trea...
CPI Inflation Data To Set Stage For Next Fed Meeting (Live Coverage)
Core CPI inflation is forecast to edge up to 2.5%....
Dow Jones recovering? Four keys to watch, Nasdaq at resistance, US CPI in focus today
Thanks to the high price of crude and the threat of interest rate rises by the Fed, the Dow Jones In...
Walmart widens food delivery push with Papa John’s partnership
Cummins Sells the Power Solutions That Keep Data Centers Running. Does That Make the Stock a Buy?
Its shares have surged so far in 2026, and there could still be plenty of upside ahead.
ECB prepares for ‘longer-lasting’ inflation as it lifts interest rates to 2.5%
Central bank’s president Christine Lagarde warns price shock driven by Middle East conflict will persist well into 2027
WEX Stock Rises 36.3% in Three Months: Here's What You Should Know
WEX's broad-based segment growth, AI integration and pricing actions support margins, cash flow and increased share buybacks.
United Rentals downgraded, Herc upgraded at J.P. Morgan on cloudy outlook
OpenAI to utilities: Buy our AI to protect the grid from our AI
SpaceX shifting gears with data center buildout, may slow expansion: report
Freightos 1H non-GAAP EPS of $0.16, revenue of $14.85M
British Pound: Consolidation against US Dollar before UK data and BoE – Scotiabank
Scotiabank strategists Shaun Osborne and Eric Theoret note GBP/USD is little changed as it extends its recovery from last week’s lows, with risk set to rise on upcoming United Kingdom (UK) trade and i ...
America is losing its captive creditors
The US is paying a higher cost to induce more price-sensitive investors to buy Treasuries
2 Reasons to Like DT and 1 to Stay Skeptical
Dynatrace has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.4%. The stock now trades at $50.44, marking a 33.6% gain. This run-up might have investors cont ...
Why Has AbbVie Gone Quiet About Humira?
AbbVie (ABBV) has returned 23.3% over the past year, ahead of the S&P 500's (SPY) 18.5%, and the business behind that return has changed shape. Humira, the drug whose decline management once explained ...